Nevro to Present at Wells Fargo 2024 Healthcare Conference
Nevro Corp. (NYSE: NVRO), a global medical device company focused on chronic pain treatment solutions, has announced its participation in the Wells Fargo 2024 Healthcare Conference. The company's management team will engage in a 'fireside chat' session on Friday, September 6, 2024, at 8:45 a.m. EDT.
Investors and interested parties can access a live webcast of the session, as well as a replay, through the Events and Presentations page in the Investors section of Nevro's website. The company regularly posts important investor information on its website and encourages stakeholders to consult it for updates.
Nevro Corp. (NYSE: NVRO), un'azienda globale di dispositivi medici focalizzata sulle soluzioni per il trattamento del dolore cronico, ha annunciato la sua partecipazione alla Wells Fargo 2024 Healthcare Conference. Il team direttivo dell'azienda parteciperà a una sessione di 'fireside chat' venerdì 6 settembre 2024, alle 8:45 EDT.
Gli investitori e le parti interessate possono accedere a un webcast dal vivo della sessione, così come a un replay, attraverso la pagina Eventi e Presentazioni nella sezione Investitori del sito web di Nevro. L'azienda pubblica regolarmente informazioni importanti per gli investitori sul proprio sito e incoraggia gli stakeholder a consultarlo per aggiornamenti.
Nevro Corp. (NYSE: NVRO), una empresa global de dispositivos médicos centrada en soluciones de tratamiento para el dolor crónico, ha anunciado su participación en la Wells Fargo 2024 Healthcare Conference. El equipo directivo de la compañía participará en una sesión de 'fireside chat' el viernes 6 de septiembre de 2024, a las 8:45 a.m. EDT.
Los inversores y partes interesadas pueden acceder a un webcast en vivo de la sesión, así como a una repetición, a través de la página de Eventos y Presentaciones en la sección de Inversores del sitio web de Nevro. La empresa publica regularmente información importante para inversores en su sitio web y anima a las partes interesadas a consultarlo para actualizaciones.
네브로 코퍼레이션 (NYSE: NVRO), 만성 통증 치료 솔루션에 중점을 둔 글로벌 의료 기기 회사가 웰스 파고 2024 의료 컨퍼런스에 참가한다고 발표했습니다. 회사의 관리 팀은 2024년 9월 6일 금요일, 오전 8시 45분 EDT에 '파이어사이드 챗' 세션에 참여할 예정입니다.
투자자와 관심 있는 분들은 네브로 웹사이트의 투자자 섹션에 있는 이벤트 및 발표 페이지를 통해 세션의 라이브 웨비나와 재생을 이용할 수 있습니다. 회사는 정기적으로 웹사이트에 중요한 투자자 정보를 게시하며, 이해 관계자들이 이를 확인하여 업데이트를 받을 것을 권장합니다.
Nevro Corp. (NYSE: NVRO), une entreprise mondiale de dispositifs médicaux axée sur des solutions de traitement de la douleur chronique, a annoncé sa participation à la Wells Fargo 2024 Healthcare Conference. L'équipe de direction de l'entreprise participera à une session de 'fireside chat' le vendredi 6 septembre 2024, à 8h45 EDT.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la session, ainsi qu'à un replay, via la page Événements et Présentations dans la section Investisseurs du site Web de Nevro. L'entreprise publie régulièrement des informations importantes pour les investisseurs sur son site Web et encourage les parties prenantes à le consulter pour des mises à jour.
Nevro Corp. (NYSE: NVRO), ein weltweit tätiges Medizinprodukteunternehmen, das sich auf Lösungen zur Behandlung chronischer Schmerzen konzentriert, hat seine Teilnahme an der Wells Fargo 2024 Healthcare Conference angekündigt. Das Management-Team des Unternehmens wird an einer 'Fireside Chat'-Sitzung am Freitag, den 6. September 2024, um 8:45 Uhr EDT teilnehmen.
Investoren und interessierte Parteien können über die Seite Veranstaltungen und Präsentationen im Bereich Investoren der Nevro-Website auf einen Live-Webcast der Sitzung sowie auf eine Wiederholung zugreifen. Das Unternehmen veröffentlicht regelmäßig wichtige Informationen für Investoren auf seiner Website und ermutigt die Stakeholder, diese für Aktualisierungen zu konsultieren.
- None.
- None.
A live webcast of the session and a replay of the webcast will be available on the Events and Presentations page in the Investors section of the company's website at www.nevro.com.
Internet Posting of Information
Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at www.nevro.com. The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.
About Nevro
Headquartered in
Nevro recently added a minimally invasive treatment option for patients suffering from chronic sacroiliac joint ("SI joint") pain and now provides the most comprehensive portfolio of products in the SI joint fusion space, designed to meet the preferences of physicians and varying patient needs in order to improve outcomes and quality of life for patients.
Senza®, Senza II®, Senza Omnia®, and HFX iQ™ are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy™. Nevro's unique support services provide every patient with HFX Coach™ support throughout their pain relief journey and every physician with HFX Cloud™ insights for enhanced patient and practice management.
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo, RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents. To learn more about Nevro, connect with us on LinkedIn, X, Facebook, and Instagram.
Investors and Media:
Angie McCabe
Vice President, Investor Relations &
Corporate Communications
angeline.mccabe@nevro.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/nevro-to-present-at-wells-fargo-2024-healthcare-conference-302232758.html
SOURCE Nevro Corp.
FAQ
When is Nevro (NVRO) participating in the Wells Fargo 2024 Healthcare Conference?
How can investors access Nevro's (NVRO) presentation at the Wells Fargo conference?
What type of session will Nevro (NVRO) be participating in at the Wells Fargo conference?
Where does Nevro (NVRO) post important information for investors?
